Cutting edge advances in nanomedicine by Han Xiao & YouYi Zhang
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2012. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
*Corresponding author (email: zhangyy@bjmu.edu.cn) 
 October 2012  Vol.55  No.10: 841–842 
• EDITORIAL • doi: 10.1007/s11427-012-4391-y 
Cutting edge advances in nanomedicine 
XIAO Han & ZHANG YouYi* 
Institute of Vascular Medicine of Peking University Third Hospital, Ministry of Health Key Laboratory of Cardiovascular Molecular Biology 
and Regulatory Peptides and Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, China 
Received September 20, 2012 
 




Nanomedicine is the application of nanotechnology in med-
icine and is a revolutionary area in medical diagnostics and 
therapeutics using nanoscientific materials, tools, techniques 
and insight. Nanotechnology is the understanding and control 
of matter and processes at the nanoscale (1–100 nm) in one 
or more dimensions where size-dependent phenomena usual-
ly enable novel applications (http://www.nano.gov/). This 
themed issue provides several reviews summarizing the 
recent development of nanotechnology in medical diagnos-
tics and therapeutics, especially cancer therapeutics. In the-
se reviews, the authors also included a lot of their own 
findings. Original articles investigated the biohazards of 
nanomaterials and provided new evidence for thrombosis 
mechanism using nano-based approach. 
Some of the earliest nanotechnological applications are 
in molecular diagnostics, especially nanoparticle-based mo-
lecular imaging. Nanoplatform-based molecular imaging 
possesses unprecedented potential for early detection, accu-
rate diagnosis, and personalized treatment of diseases [1]. 
Unique characteristics of nanoparticles make them attractive 
for molecular imaging. Because of smaller size, nanoparti-
cles have significantly higher surface area to volume ratio. 
Nanoparticle surface can be decorated with therapeutic 
molecules, imaging agents, targeting ligands, or nucleic 
acids. Tong and co-workers [2] summarized the develop-
ment of nano-structured and nanoparticle-based molecular 
imaging probes, and molecular machines using engineered 
nucleases for gene targeting. The best known nanoparticles, 
quantum dots (QDs), have been used as fluorescence imag-
ing probes. Here, they discussed QDs which can be applied 
as fluorescence imaging probes, fluorescent protein FRET 
probes and molecular beacons. The advantages of QD labels 
are their extremely high photostability, high identification 
accuracy and controllable colors. As imaging contrast 
agents, nanoparticles circulate in the blood for longer peri-
ods of time with higher sensitivity and possibly fewer 
side-effects. In addition, they introduced the development of 
novel engineered molecular machines that can quantify, 
control and manipulate biological functions in living cells 
for disease treatment. They also discussed the challenges of 
these nanotechnological applications.  
For several years, nanotechnology has been developed in 
cancer for diagnosis (detection and imaging), treatment and 
prevention [3]. The promising characteristics of nanoparti-
cles raise the development of theranostic applications which 
combine both therapeutic and diagnostic purposes [4]. 
Theranostic nanoparticles can be delivered to the target area 
for imaging while act as therapeutic agents. Nie and Chen 
[5] presented an overview of Au nanoparticles applications 
in cancer theranostics which includes cancer diagnosis (im-
aging based detection) and cancer therapy (photothermal 
therapy, anti-neoplasia and drug delivery). The ability of Au 
nanoparticles in efficient light absorption followed by rapid 
heat conversion makes them become the promising candi-
dates for cancer hyperthermia treatment. Au nanoparticles 
also have the anti-neoplastic and anti-angiogenesis effects. 
Like most nanocarriers, Au nanoparticles also have several 
advantages when serving as drug delivery vehicles. Unlike 
other antitumor agents or nanomaterials, Gd@C82(OH)22 
nanoparticles do not directly kill tumor cells but inhibit tu-
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mor growth and metastasis [6]. Li and co-workers [6] dis-
cussed Gd@C82(OH)22 nanoparticles in terms of physio-
chemical properties and antineoplastic activites, as well as 
its underlying mechanisms on tumor microenvironment 
regulation. 
Biosafety is the most concerned area in nanotechnologi-
cal applications. In vitro cell culture has been routinely used 
for nanoparticle toxicity assessment. However, excessive 
subculturing could disturb the cultured cells properties. Guo 
and co-workers [7] assessed the effects of silver nanoparti-
cels (AgNPs) on different passages of Ba/F3 cells to see if 
the cellular response upon nanomaterial exposure is con-
sistent enough to evaluate the nanoparticle toxicity. 
In basic research, nano-based technologies provide us 
new evidence or models which cannot be acquired by the 
traditional approach. Most in vitro studies usually analyze 
conventional 2D cell-culture that fail to reconstitute the in 
vivo cellular microenvironment. Three-dimensional tis-
sue-like structure models create cell-culture microenviron-
ments that both support tissue differentiation and recapitu-
late microenvironments in living organs [8]. However, it is 
still a great challenge to construct tissue-like structures with 
microscale features. Recent developments emphasize the 
nanotechnological applications for cells manipulation to 
reconstitute tissue-like structures. Gong et al. [9] summarize 
the currently available microscale methods that control 
mammalian cells to assemble into tissue-like structures. 
Nanotechnology includes visualization and manipulation 
on nanoscale. The atomic force microscope (AFM) is fre-
quently used to investigate the interaction forces (e.g., ligand 
receptor binding) and the mechanical properties of living 
material in three dimensions, with resolutions as high as 
0.1–0.2 nm. In contrast to the conventional microscope, the 
AFM can be applied in the investigation at the molecular 
level and under near physiological conditions [10]. In the 
current issue, Wei et al. [11] investigated the mechanism of 
cigarette smoking triggered thrombosis. They used AFM 
based single molecule force spectroscopy to investigate the 
thrombomodulin (TM)-thrombin binding in vitro and in 
living cells. They found that cigarette smoke extract (CSE)  
treatment dose-dependently lowers binding probability for 
thrombin and TM extracellular domain (TM-ECD) binding 
onto the silicon substrate. Interestingly, they discovered that 
CSE did not affect the thrombin/TM binding force. Using 
AFM combined with fluorescence microscopy, they inves-
tigated the single-molecule force of thrombin/TM in the 
living cells expressing TM-EGFP. They also found that 
CSE dramatically reduces the binding probability of throm-
bin/TM in the living cells. In conclusion, CSE inhibits 
thrombin/TM binding both in vitro and in living cells [11].  
The main goal of this themed issue is to provide a survey 
of how nanomaterials and nanotechnology improve our 
basic and clinical research. We hope that you will find them 
inspiring and useful for your research. 
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